VANCOMYCIN HCL
VANCOMYCIN INTRAVENOUS·CLOSTRIDIOIDES DIFFICILE INFECTION·+18
FRESENIUS KABI
Indication
Streptococcal endocarditis
Streptococcal endocarditis is an infective endovascular condition characterized by bacterial infection of the heart's endocardium, most frequently colonizing native or prosthetic heart valves. Read more about Streptococcal endocarditis
109 drugs 57 manufacturers
Drugs that treat it
Common Streptococcal endocarditis therapies.
VANCOMYCIN HCL
VANCOMYCIN INTRAVENOUS·CLOSTRIDIOIDES DIFFICILE INFECTION·+18
GLENMARK PHARMA
AMPICILLIN SODIUM
BETA-LACTAMS·TYPHOID FEVER·+31
Avet Pharmaceuticals
VANCOMYCIN HCL
VANCOMYCIN INTRAVENOUS·CLOSTRIDIOIDES DIFFICILE INFECTION·+18
MEDIMETRIKS PHA
TYZAVAN (vancomycin HCl in water for injection (NADA,lysine))
VANCOMYCIN INTRAVENOUS·CLOSTRIDIOIDES DIFFICILE INFECTION·+18
Hikma Pharmaceuticals USA
AMPICILLIN SODIUM
BETA-LACTAMS·TYPHOID FEVER·+31
METHAPHARM/AVET
VANCOMYCIN HCL
VANCOMYCIN INTRAVENOUS·CLOSTRIDIOIDES DIFFICILE INFECTION·+18
X-GEN PHARMACEU
VANCOMYCIN HCL
VANCOMYCIN INTRAVENOUS·CLOSTRIDIOIDES DIFFICILE INFECTION·+18
AVENACY, INC
CEFAZOLIN SODIUM-0.9% NACL (cefazolin sodium in 0.9 % sodium chloride)
BETA-LACTAMS·BACTERIAL SEPSIS·+14
WELLS PHARMA OF
Filter & compare in the drug finder →Opens the drug finder with Streptococcal endocarditis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonStreptococcal endocarditis is an infective endovascular condition characterized by bacterial infection of the heart's endocardium, most frequently colonizing native or prosthetic heart valves.
It is predominantly caused by viridans group streptococci, *Streptococcus gallolyticus*, or other streptococcal species that enter the bloodstream and adhere to pre-existing endothelial lesions or platelet-fibrin thrombi.
Pathophysiologically, the bacteria proliferate within protected vegetations, prompting local valvular destruction, regurgitation, and intracardiac abscesses, as well as systemic complications such as embolic phenomena and immune-mediated vasculitis.
Patients typically present with a subacute or acute clinical course featuring fever, fatigue, new or changing cardiac murmurs, and potentially life-threatening congestive heart failure.
- nih.gov
Streptococcal endocarditis is an infective endovascular condition characterized by bacterial infection of the heart's endocardium, most frequently colonizing native or prosthetic heart valves
- nih.gov
Streptococcal endocarditis is an infective endovascular condition characterized by bacterial infection of the heart's endocardium, most frequently colonizing native or prosthetic heart valves
- mayoclinic.org
Streptococcal endocarditis is an infective endovascular condition characterized by bacterial infection of the heart's endocardium, most frequently colonizing native or prosthetic heart valves Patients typically present with a subacute or acute clinical course featuring fever, fatigue, new or changing cardiac murmurs, and potentially life-threatening congestive heart failure
- nih.gov
It is predominantly caused by viridans group streptococci, *Streptococcus gallolyticus*, or other streptococcal species that enter the bloodstream and adhere to pre-existing endothelial lesions or platelet-fibrin thrombi
- cdc.gov
It is predominantly caused by viridans group streptococci, *Streptococcus gallolyticus*, or other streptococcal species that enter the bloodstream and adhere to pre-existing endothelial lesions or platelet-fibrin thrombi Pathophysiologically, the bacteria proliferate within protected vegetations, prompting local valvular destruction, regurgitation, and intracardiac abscesses, as well as systemic complications such as embolic phenomena and immune-mediated vasculitis
- nih.gov
It is predominantly caused by viridans group streptococci, *Streptococcus gallolyticus*, or other streptococcal species that enter the bloodstream and adhere to pre-existing endothelial lesions or platelet-fibrin thrombi
- regionh.dk
Pathophysiologically, the bacteria proliferate within protected vegetations, prompting local valvular destruction, regurgitation, and intracardiac abscesses, as well as systemic complications such as embolic phenomena and immune-mediated vasculitis
- nih.gov
Patients typically present with a subacute or acute clinical course featuring fever, fatigue, new or changing cardiac murmurs, and potentially life-threatening congestive heart failure
Personalize your experience
Follow Streptococcal endocarditis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.